- Home
- MCRB vs RAYA Comparison
MCRB vs RAYA Comparison
Compare MCRB & RAYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MCRB
- RAYA
- Stock Information
- Founded
- MCRB 2010
- RAYA 2019
- Country
- MCRB United States
- RAYA China
- Employees
- MCRB N/A
- RAYA N/A
- Industry
- MCRB Biotechnology: Pharmaceutical Preparations
- RAYA Metal Fabrications
- Sector
- MCRB Health Care
- RAYA Consumer Discretionary
- Exchange
- MCRB Nasdaq
- RAYA Nasdaq
- Market Cap
- MCRB 103.7M
- RAYA 103.6M
- IPO Year
- MCRB 2015
- RAYA 2022
- Fundamental
- Price
- MCRB $12.09
- RAYA $2.53
- Analyst Decision
- MCRB Hold
- RAYA
- Analyst Count
- MCRB 4
- RAYA 0
- Target Price
- MCRB $73.67
- RAYA N/A
- AVG Volume (30 Days)
- MCRB 109.0K
- RAYA 548.6K
- Earning Date
- MCRB 08-12-2025
- RAYA 01-01-0001
- Dividend Yield
- MCRB N/A
- RAYA N/A
- EPS Growth
- MCRB N/A
- RAYA N/A
- EPS
- MCRB 8.98
- RAYA N/A
- Revenue
- MCRB N/A
- RAYA $30,300,360.00
- Revenue This Year
- MCRB N/A
- RAYA $20.95
- Revenue Next Year
- MCRB N/A
- RAYA N/A
- P/E Ratio
- MCRB $1.50
- RAYA N/A
- Revenue Growth
- MCRB N/A
- RAYA 49.10
- 52 Week Low
- MCRB $6.53
- RAYA $0.56
- 52 Week High
- MCRB $30.60
- RAYA $3.14
- Technical
- Relative Strength Index (RSI)
- MCRB 66.74
- RAYA 58.42
- Support Level
- MCRB $10.67
- RAYA $2.31
- Resistance Level
- MCRB $12.84
- RAYA $2.99
- Average True Range (ATR)
- MCRB 1.09
- RAYA 0.41
- MACD
- MCRB 0.34
- RAYA 0.01
- Stochastic Oscillator
- MCRB 85.98
- RAYA 58.50
About MCRB Seres Therapeutics Inc.
Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treat dysbiosis in the colonic microbiome. SER-109, the company's product, is designed to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon. In addition, the company is involved in developing SER-262, SER-287, and SER-401.
About RAYA Erayak Power Solution Group Inc.
Erayak Power Solution Group Inc engages in manufacturing, research and development, and wholesale and retail of power solution products. Its product portfolio includes sine wave and off-grid inverters, inverter and gasoline generators, battery, and smart chargers, and custom-designed products. It derives the majority revenue from four products namely inverters, chargers, power bank, and gasoline generators. The company generates the majority of its revenue from Inverters. The company geographically operates in China, Australia, Poland, U.K., and Germany. It derives maximum revenue from China.